Researchers have developed a technique that uses artificial intelligence to obtain medical images...
Artificial intelligence scanner could improve medical imaging
Researchers have developed a technique that uses artificial intelligence to obtain medical images without costly or dangerous increases in doses of radiation.
Gore and Bonbouton to study smart fabric solutions for digital health
Medical devices developer WL Gore & Associates has partnered with digital health start-up Bonbouton to carry out research on advanced sensor technology and develop smart fabrics with applications as assistive apparel and digital health monitors.
Wearable brain scanner measures activity while patients move
A new generation of brain scanner can be worn like a helmet, allowing patients to move naturally while being scanned.
Molecular imaging: nipping drug failure in the bud
The UK’s National Measurement Institute (NPL) recently launched the 3D OrbiSIMS, an innovative molecular imaging instrument that could help determine drug failures earlier in the development process. Abi Millar investigates how the tool might improve attrition rates.
Advantis Medical secures CE-Mark for neuroimaging software
Advantis Medical Imaging has secured the European CE-Mark for the use of its cloud-based neuroimaging software called Brainance MD as part of the clinical workflow in advanced processing of brain magnetic resonance (MR) images.
Device lets patients control their own sedation during operations
Patients undergoing operations while awake will be able to administer their own doses of intravenous sedation at the touch of a button.
Two trials find Medtronic’s algorithm reduces atrial fibrillation
Medtronic has reported successful findings from two real-world analyses conducted to assess its AdaptivCRT algorithm in a total of 408 patients suffering from heart failure.
Artificially-produced diamonds could improve brain imaging
Researchers have optimised the design of laboratory-grown artificial diamonds for use in biosensing applications such as magnetic brain imaging.
Novartis to develop Harvard’s biomaterial-based cancer immunotherapies
The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have granted British pharmaceutical company Novartis access to commercially develop their therapeutic, biomaterial-based, cancer vaccine technology.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.